Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Res Int ; 172: 113158, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37689911

RESUMEN

Conjugated linoleic acid (CLA) has attracted great attention in recent years as a popular class of functional food that is broadly used. It refers to a group of geometric and positional isomers of linoleic acid (LA) with a conjugated double bond. The main natural sources of CLA are dairy products, beef and lamb, whereas only trace amounts occur naturally in plant lipids. CLA has been shown to improve various health issues, having effects on obesity, inflammatory, anti-carcinogenicity, atherogenicity, immunomodulation, and osteosynthesis. Also, compared to studies on humans, many animal researches reveal more positive benefits on health. CLA represents a nutritional avenue to improve lifestyle diseases and metabolic syndrome. Most of these effects are attributed to the two major CLA isomers [conjugated linoleic acid cis-9,trans-11 isomer (c9,t11), and conjugated linoleic acid trans-10,cis-12 isomer (t10,c12)], and their mixture (CLA mix). In contrast, adverse effects of CLA have been also reported, such as glucose homeostasis, insulin resistance, hepatic steatosis and induction of colon carcinogenesis in humans, as well as milk fat inhibition in ruminants, lowering chicken productivity, influencing egg quality and altering growth performance in fish. This review article aims to discuss the health benefits of CLA as a nutraceutical supplement and highlight the possible mechanisms of action that may contribute to its outcome. It also outlines the feasible adverse effects of CLA besides summarizing the recent peer-reviewed publications on CLA to ensure its efficacy and safety for proper application in humans.


Asunto(s)
Alimentos Funcionales , Ácidos Linoleicos Conjugados , Bovinos , Humanos , Animales , Ovinos , Suplementos Dietéticos , Carcinogénesis , Pollos
2.
Vet Sci ; 10(2)2023 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-36851378

RESUMEN

(1) Background: Cystic echinococcosis is a zoonotic helminth disease that causes severe economic losses. The study aimed to assess the prevalence and viability of cystic echinococcosis in examined camels. In addition, assessing the histological, morphological, oxidative, and antioxidant state related to the cystic echinococcosis infection; (2) Methods: The study was performed on 152 slaughtered dromedary camels between March and September 2022 at El-Basatin abattoir in Cairo Governorate, Egypt; (3) Results: The results revealed that the prevalence of hydatidosis was 21.7% in slaughtered camel and the highest infection rate observed in lungs was 87.87%, while it was 9% in livers. Camels' liver infections were rare, whereas their lung infections were more common. By comparing to non-infected camels, the level of MAD was significantly increased with hydatid cysts infection, while the level of GSH, SOD and CAT was significantly decreased. Histopathological section of camel cyst revealed layered membranes surrounded by a zone of cellular infiltration and an outermost fibrous tissue reaction. In addition, there was evidence of atelectasis, emphysema, hemorrhage, congestion, and fibrosis in the surrounding tissues. Nonetheless, the degeneration and necrosis of hepatocytes and other pathological alterations in liver cyst sections were remarkably comparable to those seen in the lungs. Furthermore, calcification was detected.

3.
BMC Vet Res ; 19(1): 29, 2023 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-36721142

RESUMEN

Animal production is greatly affected by Q fever. As a result of a lack of methodology and financial means to perform extensive epidemiological surveys, the disease's underdiagnosis has proven to be a challenge for effective control. The present study aimed to determine the seroprevalence of C. burnetii in cattle raising in four governorates situated at Nile Delta of Egypt and assess the associated risk factors for infection. A total of 480 serum samples were collected from cattle and examined for presence of anti-C. burnetii antibodies using indirect ELISA assay. The overall seroprevalence of C. burnetii among examined cattle was 19.8%, with the Qalyubia governorate having the highest prevalence. The results of multivariable logistic regression analysis revealed significant association between C. burnetii seropositivity and age, communal grazing and/or watering, contact with small ruminants and history of infertility. According to the findings of this work, C. burnetii is circulating among cattle living in Nile Delta. It is suggested that adequate hygiene procedures and biosecurity measures should be implemented to limit the transmission of pathogens within cow herds and potential human exposure.


Asunto(s)
Enfermedades de los Bovinos , Coxiella burnetii , Fiebre Q , Femenino , Humanos , Bovinos , Animales , Egipto/epidemiología , Estudios Seroepidemiológicos , Fiebre Q/epidemiología , Fiebre Q/veterinaria , Factores de Riesgo , Enfermedades de los Bovinos/epidemiología
5.
Front Cell Infect Microbiol ; 12: 855731, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35646746

RESUMEN

Mycoplasmas as economically important and pantropic pathogens can cause similar clinical diseases in different hosts by eluding host defense and establishing their niches despite their limited metabolic capacities. Besides, enormous undiscovered virulence has a fundamental role in the pathogenesis of pathogenic mycoplasmas. On the other hand, they are host-specific pathogens with some highly pathogenic members that can colonize a vast number of habitats. Reshuffling mycoplasmas genetic information and evolving rapidly is a way to avoid their host's immune system. However, currently, only a few control measures exist against some mycoplasmosis which are far from satisfaction. This review aimed to provide an updated insight into the state of mycoplasmas as pathogens by summarizing and analyzing the comprehensive progress, current challenge, and future perspectives of mycoplasmas. It covers clinical implications of mycoplasmas in humans and domestic and wild animals, virulence-related factors, the process of gene transfer and its crucial prospects, the current application and future perspectives of nanotechnology for diagnosing and curing mycoplasmosis, Mycoplasma vaccination, and protective immunity. Several questions remain unanswered and are recommended to pay close attention to. The findings would be helpful to develop new strategies for basic and applied research on mycoplasmas and facilitate the control of mycoplasmosis for humans and various species of animals.


Asunto(s)
Infecciones por Mycoplasma , Mycoplasma , Animales , Mycoplasma/genética , Virulencia/genética , Factores de Virulencia/genética
6.
Viruses ; 13(11)2021 10 27.
Artículo en Inglés | MEDLINE | ID: mdl-34834973

RESUMEN

Bovine leukaemia virus (BLV) is a deltaretrovirus that is closely related to human T-cell leukaemia virus types 1 and 2 (HTLV-1 and -2). It causes enzootic bovine leukosis (EBL), which is the most important neoplastic disease in cattle. Most BLV-infected cattle are asymptomatic, which potentiates extremely high shedding rates of the virus in many cattle populations. Approximately 30% of them show persistent lymphocytosis that has various clinical outcomes; only a small proportion of animals (less than 5%) exhibit signs of EBL. BLV causes major economic losses in the cattle industry, especially in dairy farms. Direct costs are due to a decrease in animal productivity and in cow longevity; indirect costs are caused by restrictions that are placed on the import of animals and animal products from infected areas. Most European regions have implemented an efficient eradication programme, yet BLV prevalence remains high worldwide. Control of the disease is not feasible because there is no effective vaccine against it. Therefore, detection and early diagnosis of the disease are essential in order to diminish its spreading and the economic losses it causes. This review comprises an overview of bovine leukosis, which highlights the epidemiology of the disease, diagnostic tests that are used and effective control strategies.


Asunto(s)
Leucosis Bovina Enzoótica/epidemiología , Leucosis Bovina Enzoótica/virología , Virus de la Leucemia Bovina , Animales , Bovinos , Pruebas Diagnósticas de Rutina , Leucosis Bovina Enzoótica/diagnóstico , Leucosis Bovina Enzoótica/transmisión , Femenino , Genoma Viral , Virus Linfotrópico T Tipo 1 Humano , Virus de la Leucemia Bovina/genética , Prevalencia , Virulencia
7.
Vet Sci ; 8(11)2021 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-34822626

RESUMEN

Infectious bovine rhinotracheitis (IBR), caused by bovine alphaherpesvirus 1 (BoHV-1), is an important disease affecting cattle worldwide resulting in great economic losses. Marker vaccines are effective in controlling infectious diseases including IBR, because they allow the discrimination between the natural infection and the vaccination. Therefore, a triple gene deleted strain BoHV-1 gG-/tk-/gE- was developed and evaluated in vivo and in vitro as a marker vaccine. In cell culture, this triple mutant virus showed significantly slower growth kinetics and smaller plaques when compared to wild-type (wt) BoHV-1 and double mutant BoHV-1 gG-/tk- (p < 0.01). On proteomic level, it revealed downregulation of some virulence related proteins including thymidine kinase, glycoproteins G, E, I, and K when compared to the wt. In vitro, the triple mutant virus showed a significantly lower and shorter viral shedding period (p < 0.001) in calves compared to double mutant. Moreover, the immunized calves with triple mutant virus showed protection rates of 64.2% and 68.6% against wt BoHV-1 and wt BoHV-5 challenge, respectively, without reactivation of latency after dexamethasone injection. In conclusion, BoHV-1 gG-/tk-/gE- is a safer marker vaccine against IBR although its immunogenicity in calves was decreased when compared to double mutant virus.

8.
Crit Rev Toxicol ; 51(9): 754-787, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-35274591

RESUMEN

Ciprofloxacin (CIP) (human use) and enrofloxacin (ENR) (veterinary use) are synthetic anti-infectious medications that belong to the second generation of fluoroquinolones. They have a wide antimicrobial spectrum and strong bactericidal effects at very low concentrations via enzymatic inhibition of DNA gyrase and topoisomerase IV, which are required for DNA replication. They also have high bioavailability, rapid absorption with favorable pharmacokinetics and excellent tissue penetration, including cerebral spinal fluid. These features have made them the most applied antibiotics in both human and veterinary medicine. ENR is marketed exclusively for animal medicine and has been widely used as a therapeutic veterinary antibiotic, resulting in its residue in edible tissues and aquatic environments, as well as the development of resistance and toxicity. Estimation of the risks to humans due to antimicrobial resistance produced by CIP and ENR is important and of great interest. Moreover, in rare cases due to their overdose and/or prolonged administration, the development of CIP and ENR toxicity may occur. The toxicity of these fluoroquinolones antimicrobials is mainly related to reactive oxygen species (ROS) and oxidative stress (OS) generation, besides metabolism-related toxicity. Therefore, CIP is restricted in pregnant and lactating women, pediatrics and elderly similarly ENR do in the veterinary field. This review manuscript aims to identify the toxicity induced by ROS and OS as a common sequel of CIP and ENR. Furthermore, their metabolism and the role of metabolizing enzymes were reported.


Asunto(s)
Antiinfecciosos , Ciprofloxacina , Anciano , Animales , Niño , Ciprofloxacina/química , Ciprofloxacina/metabolismo , Ciprofloxacina/toxicidad , Enrofloxacina , Femenino , Fluoroquinolonas/química , Fluoroquinolonas/toxicidad , Humanos , Lactancia , Estrés Oxidativo , Embarazo , Especies Reactivas de Oxígeno
9.
Pathogens ; 9(9)2020 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-32967149

RESUMEN

Mycoplasma bovis is a major pathogen, responsible for bovine respiratory diseases worldwide. The present lack of effective control measures leaves cattle owners at considerable perpetual risk of M. bovis outbreaks. In this study, we identified M. bovis secreted immunogenic proteins in silico as potential candidates for novel diagnostic agents and vaccines. We used immunoinformatics to analyze 438 M. bovis proteins previously identified with a label-free proteomics analysis of virulent M. bovis HB0801 (P1) and its attenuated P150 strains. The subcellular localization of these proteins was preliminarily screened and 59 proteins were found to be secreted extracellular proteins. Twenty-seven of these proteins contained a large number of predictive T-cell epitopes presented by major histocompatibility complex (MHC) class I and II molecules. Twenty-two of these 27 proteins had a high number of conformational B-cell epitopes, predicted from the corresponding 3D structural templates, including one unique to P1, two unique to P150, and 19 common to both strains. Five proteins were selected for further validation, and two of these, MbovP274 and MbovP570, were successfully expressed and purified. Both were confirmed to be secretory and highly immunogenic proteins that induced a mouse antibody response, reacted with cattle serum positive for M. bovis infection, and significantly increased the production of interleukin 8 (IL-8), IL-12 and interferon γ (IFN-γ) during the secretion of these three cytokines by both M. bovis mutants of these genes. These results should be useful in the development of novel immunological agents against M. bovis infection.

10.
Microb Pathog ; 144: 104160, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32194181

RESUMEN

Bacterial secretome is a comprehensive catalog of bacterial proteins that are released or secreted outside the cells. They offer a number of factors that possess several significant roles in virulence as well as cell to cell communication and hence play a core role in bacterial pathogenesis. Sometimes these proteins are bounded with membranes giving them the shape of vesicles called extracellular vesicles (EVs) or outer membrane vesicles (OMVs). Bacteria secrete these proteins via Sec and Tat pathways into the periplasm. Secreted proteins have found to be important as diagnostic markers as well as antigenic factors for the development of an effective candidate vaccine. Recently, the research in the field of secretomics is growing up and getting more interesting due to their direct involvement in the pathogenesis of the microorganisms leading to the infection. Many pathogenic bacteria have been studied for their secretome and the results illustrated novel antigens. This review highlights the secretome studies of different pathogenic bacteria in humans and animals, general secretion mechanisms, different approaches and challenges in the secretome of Mycoplasma sp.


Asunto(s)
Vesículas Extracelulares/fisiología , Mycoplasma/metabolismo , Mycoplasma/patogenicidad , Percepción de Quorum/fisiología , Factores de Virulencia/metabolismo , Membrana Externa Bacteriana/fisiología , Transporte de Proteínas/fisiología , Proteoma/metabolismo , Transducción de Señal/fisiología
11.
Microb Pathog ; 143: 104135, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32165330

RESUMEN

Mycoplasma bovis is a risky pathogen mainly responsible for pneumonia and mastitis in cattle. Up to date, its pathogenesis is not clear. Since secreted proteins have a tricky role in M. bovis pathogenesis, this study was designed to systematically reveal M. bovis secretome and potential role in virulence of the pathogen. By using bioinformatics tools, a total of 246 secreted proteins were predicted based on M. bovis genome. Among them, 14 were classical, 154 non-classical and 78 both pathways. Then by using 2-dimensional gel electrophoresis (2-DE) and Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF- MS), 169 proteins were revealed. Of them, 60 were predicted to be secreted including 3 classical, 43 non-classical, and 14 both classical and non-classical. Further 8 proteins (MbovP0038, MbovP0338, MbovP0341, MbovP0520, MbovP0581, MbovP0674, MbovP0693, MbovP0845) were predicted to be virulence-related factors with VFDB. In addition, MbovP0581 (ABC transporter protein) was validated experimentally as secreted in nature and highly immunogenic reacting with sera of cattle experimentally infected with M. bovis. In conclusion, this study might be a crucial step towards a better understanding of pathogenesis and leading to the development of novel diagnostic marker and potent vaccine against M. bovis.


Asunto(s)
Proteínas Bacterianas/metabolismo , Mycoplasma bovis/metabolismo , Anticuerpos Antibacterianos/inmunología , Proteínas Bacterianas/genética , Proteínas Bacterianas/inmunología , Secuencia Conservada/genética , Electroforesis en Gel Bidimensional , Genoma Bacteriano/genética , Genómica , Espectrometría de Masas , Mycoplasma bovis/genética , Mycoplasma bovis/patogenicidad , Proteómica , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Virulencia
12.
Trop Anim Health Prod ; 52(3): 1207-1210, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31686339

RESUMEN

Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis. It causes significant economic losses associated with losses due to slaughter and eradication of infected animal from infected area and other indirect economic losses such as restriction on importation of animals and semen from infected area. The main objective of this study was to determine the seroprevalence of BLV antibodies in cattle, buffaloes, and camels in Egypt using ELISA test. Serum samples were collected from 350 cattle, 100 buffaloes, and 100 camels during 2018. The seropositivity for BLV-specific antibody was 20.8%, 9%, and 0% in cattle, buffaloes, and camels, respectively. The result revealed significant association (p < 0.05) between age and seroprevalence of BLV infection in cattle > 4 years (24%) compared with those < 4 years (13%). We found no significant association between pregnancy and herd size and seroprevalence of BLV infection in this study (p > 0.05). Furthermore, the age, pregnancy state, and herd size had significant effect on seroprevalence of BLV infection in buffaloes. This study contributes that BLV is detected in cattle and buffaloes in Egypt and confirms that the camels has resistance against BLV infection. Hence, the control measures are very necessary to combat the transmission of the disease and reduce its economic impact.


Asunto(s)
Búfalos/virología , Camelus/virología , Leucosis Bovina Enzoótica/virología , Virus de la Leucemia Bovina/aislamiento & purificación , Animales , Anticuerpos Antivirales/sangre , Bison , Camelus/inmunología , Bovinos , Egipto/epidemiología , Leucosis Bovina Enzoótica/epidemiología , Leucosis Bovina Enzoótica/inmunología , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Virus de la Leucemia Bovina/inmunología , Masculino , Embarazo , Estudios Seroepidemiológicos
13.
Vet World ; 11(9): 1331-1337, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30410242

RESUMEN

AIM: This study was designed to investigate the current epidemiological situation of bovine viral diarrhea virus (BVDV) and rift valley fever virus (RVFV) infection of camels originating from Sudan "smuggler" and Egypt as part of our future plan for a national surveillance program in Egyptian provinces, which will aid in establishment of control strategy for animal diseases. MATERIALS AND METHODS: This investigation was accomplished using serological diagnostic and molecular biology techniques. A total number of 200 blood samples were collected from camel (120 originated from Sudan "smuggler" and 80 from local breed) and were subjected for testing both BVDV and RVFV occurrence with different age and sex. RESULTS: Sixty-six of the 200 camels (33%) were positive for BVDV antibodies, and 44 (22%) for BVDV antigen (Ag), and 27 of the 200 camels (13.5%) were positive for RVFV immunoglobulin G (IgG) antibodies. On the other hand, the seroprevalence of BVDV for antibodies (47.5%), Ag (31.6%), and RVFV IgG antibodies (16.6%) was higher in camel originated from Sudan "smuggler" than of local breed which was 11.2% for BVDV antibodies and 7.5% for BVDV Ag, while it was 8.7% for RVFV IgG antibodies. The incidence of BVDV antibodies, Ag, and RVFV IgG antibodies was the highest in male, up to 9 years of age. The frequency of positive cases was significantly different according to the origin of samples and sex and age of camel for BVDV and RVFV. In addition, seven serologically positive samples for BVDV and five serologically positive samples for RVFV were submitted as a buffy coat for molecular detection by one-step - reverse transcription polymerase chain reaction (RT-PCR). The results demonstrated that three samples were positive for BVDV of camel originated from Sudan (smuggler), while no RVFV Ag was detected in all five samples. Sequencing and phylogenetic analysis of the amplicons obtained from positive RT-PCR samples (three samples) indicated 100% nucleotide homology with Sudan strain 2015 except only one (missense point mutation) by substitution of A to T at position 345 that changed the coded amino acids from T (Threonine) to S (Serine) at residue 115. CONCLUSION: Camels act as risk animals for the introduction of many infectious diseases from Sudan to Egypt, especially transboundary animal diseases, so strict quarantine measures should be taken during importation of live animals from Sudan to prevent the spread of such diseases.

14.
Int J Dermatol ; 57(4): 449-457, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29417554

RESUMEN

BACKGROUND: Myiasis induced by the sheep blowfly, Lucilia sericata, represents a public health problem widely distributed throughout the world. L. sericata larval stages feed on both humans and animals. L. sericata adults and larvae can play a role in spreading agents of mycobacterial infections. OBJECTIVES: It is critical to establish new and safe alternative methods of controlling L. sericata. METHODS: The insecticidal effectiveness and growth inhibition potential of three commercially available essential oils (EOs), vetiver (Chrysopogon zizanioides), cinnamon (Cinnamomum zeylanicum), and lavender (Lavandula angustifolia), as well as their blends, were tested against the second (L2) and third (L3) larval stages of L. sericata. Sunflower (Helianthus annuus) oil was used as a carrier and tested on L2 and L3 larvae. To the best of our knowledge, all applied essential oils, except lavender, and oil blends were tested against L. sericata for the first time. RESULTS: All applied oils did not repel L2 from the treated liver but adversely affected their development. Contact treatments on L. sericata L3 indicated that vetiver and cinnamon oils significantly affected treated larvae. Total mortality rates were 93.33 and 95.56%, respectively. Furthermore, oil blends tested through contact assays killed larvae when used at higher concentrations; adult emergence was eliminated post-treatment with doses >30% for oil blend 1 and >10% for oil blend 2. CONCLUSION: Overall, cinnamon and vetiver oils (5%) were selected as reliable and cheap biopesticides for controlling larvae of L. sericata. The tested oils are inexpensive and represent new promising botanical insecticides in the fight against blowflies causing myiasis.


Asunto(s)
Chrysopogon , Cinnamomum zeylanicum , Dípteros/efectos de los fármacos , Larva/efectos de los fármacos , Aceites Volátiles/farmacología , Aceites de Plantas/farmacología , Animales , Agentes de Control Biológico/farmacología , Dípteros/crecimiento & desarrollo , Control de Insectos/métodos , Repelentes de Insectos/farmacología , Larva/crecimiento & desarrollo , Lavandula , Pupa/efectos de los fármacos , Aceite de Girasol/farmacología
15.
J Vet Med Sci ; 79(5): 912-916, 2017 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-28331116

RESUMEN

To understand how the latest dominant bovine leukemia virus (BLV) strains were introduced and spread in the Miyazaki prefecture, we collected blood samples from 3 geographic areas (north, central and south) and carried out sequence analysis of the BLV env gene. Two genotypes, genotype I, and III, were identified and the majority of the strains belonged to genotype I (71/74). To clarify a route of BLV introduction, we divided the strains into 20 subgenotypes based on their nucleotide sequences and performed phylogenetic analysis. Our study indicated that common BLV strains were comparatively evenly distributed even in the area, where the farmers have not introduced cattle from other areas and the cattle have limited exposure to BLV infection in grazing fields.


Asunto(s)
Leucosis Bovina Enzoótica/virología , Genes env , Virus de la Leucemia Bovina/genética , Animales , Bovinos , ADN Viral , Japón , Filogenia , Análisis de Secuencia de ADN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...